Alignment Healthcare (NASDAQ:ALHC) President Dawn Christine Maroney Sells 29,113 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 29,113 shares of the firm’s stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $17.45, for a total transaction of $508,021.85. Following the completion of the transaction, the president directly owned 963,702 shares of the company’s stock, valued at approximately $16,816,599.90. This represents a 2.93% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Tuesday, February 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.63, for a total transaction of $618,900.00.
• On Thursday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $22.48, for a total transaction of $674,400.00.
• On Tuesday, January 6th, Dawn Christine Maroney sold 228,152 shares of Alignment Healthcare stock. The shares were sold at an average price of $21.33, for a total value of $4,866,482.16.
• On Friday, January 2nd, Dawn Christine Maroney sold 100,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.03, for a total value of $2,003,000.00.
• On Monday, December 29th, Dawn Christine Maroney sold 282,070 shares of Alignment Healthcare stock. The stock was sold at an average price of $18.74, for a total value of $5,285,991.80.
• On Monday, December 15th, Dawn Christine Maroney sold 113,319 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.01, for a total value of $2,267,513.19.

Alignment Healthcare Stock Down 0.8%

Shares of ALHC stock opened at $16.99 on Friday. The stock’s 50-day simple moving average is $20.76 and its 200-day simple moving average is $18.73. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.71 and a current ratio of 1.71. The firm has a market capitalization of $3.47 billion, a PE ratio of -1,697.30, a P/E/G ratio of 2.50 and a beta of 1.18. Alignment Healthcare, Inc. has a fifty-two week low of $11.63 and a fifty-two week high of $23.87.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, February 26th. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.10. The firm had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1 billion. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The company’s revenue was up 44.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.16) earnings per share. Equities analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Hedge Funds Weigh In On Alignment Healthcare

Several large investors have recently made changes to their positions in ALHC. Vanguard Group Inc. grew its position in Alignment Healthcare by 10.9% during the fourth quarter. Vanguard Group Inc. now owns 15,492,802 shares of the company’s stock valued at $305,983,000 after buying an additional 1,524,218 shares during the period. Wellington Management Group LLP boosted its stake in shares of Alignment Healthcare by 26.9% during the 4th quarter. Wellington Management Group LLP now owns 14,070,893 shares of the company’s stock worth $277,900,000 after acquiring an additional 2,981,166 shares in the last quarter. T. Rowe Price Investment Management Inc. boosted its stake in shares of Alignment Healthcare by 0.6% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company’s stock worth $249,715,000 after acquiring an additional 79,268 shares in the last quarter. Invesco Ltd. grew its position in shares of Alignment Healthcare by 38.9% during the 4th quarter. Invesco Ltd. now owns 6,202,592 shares of the company’s stock valued at $122,501,000 after acquiring an additional 1,735,962 shares during the period. Finally, Hood River Capital Management LLC grew its position in shares of Alignment Healthcare by 6.0% during the 2nd quarter. Hood River Capital Management LLC now owns 5,517,336 shares of the company’s stock valued at $77,243,000 after acquiring an additional 311,424 shares during the period. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on ALHC. Robert W. Baird set a $28.00 price objective on shares of Alignment Healthcare in a research note on Friday, January 30th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alignment Healthcare in a report on Wednesday, January 21st. TD Cowen increased their price target on Alignment Healthcare from $18.50 to $25.00 and gave the stock a “buy” rating in a research report on Friday, January 16th. JPMorgan Chase & Co. lifted their price objective on Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Finally, Wall Street Zen cut Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, March 7th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $24.56.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.